This could be due to viral hepatitis screening done before blood transfusions and the subsequently increased detection and treatment of hepatitis C. Another factor may be hepatitis B vaccination, which began in 1994 in Iran, which has impacted certain countries over time [10]. This evidence concerns the gene PPIB and animal viral hepatitis.